米国の手術用ロボット市場の評価：コンポーネントタイプ別、手術タイプ別、エンドユーザー別、地域別、機会、機会および予測、2018～2032年

米国の手術用ロボット市場規模は2024年に69億6,000万米ドルと推計され、2032年には162億9,000万米ドルに達すると予測され、2025年から2032年までのCAGRは11.21%で成長しています。米国の手術用ロボット市場の成長には、低侵襲手術の増加、慢性疾患の罹患率の増加、老人人口の増加、技術の進歩、外来手術センターにおける手術用ロボットの普及の増加、政府の制度など、複数の要因が寄与しています。

手術用ロボット技術は、従来の手術に比べて、精密さ、出血量の減少、回復時間の短縮など、いくつかの利点があるため、米国ではますます人気が高まっています。米国の手術用ロボット市場は、神経外科、SBRT（定位体放射線治療）、整形外科などの新しい外科分野での用途拡大に注力しています。

目次

第1章 調査手法

第2章 製品概要

第3章 エグゼクティブサマリー

第4章 米国の手術用ロボット市場の展望、2018年～2032年

• 市場規模と予測
  • 金額別
  • 数量別
• 市場シェアと予測
  • コンポーネント別
    • システム
    • アクセサリー
    • サービス
  • 手術タイプ別
    • 婦人科
    • 泌尿器科
    • 脳神経外科
    • 整形外科
    • 一般外科
    • その他
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北東部
    • 南西部
    • 西部
    • 南東部
    • 中西部
  • 市場シェア（％）企業別、2024年

第5章 米国の手術用ロボット機器市場マッピング、2024年

• コンポーネント別
• 手術タイプ別
• エンドユーザー別
• 地域別

第6章 マクロ環境と産業構造

• 供給需要分析
• 輸入輸出分析
• バリューチェーン分析
• 手術用ロボット機器市場のPESTEL分析
  • 政治的要因
  • 経済システム
  • 社会的影響
  • 技術の進歩
  • 環境への影響
  • 法令遵守と規制ポリシー（法定機関を含む）
• ポーターのファイブフォース分析
  • サプライヤーの力
  • 買い手の力
  • 代替の脅威
  • 新規参入の脅威
  • 競争企業間の敵対関係

第7章 市場力学

• 動向と発展
• 成長促進要因
• 成長抑制要因

第8章 規制枠組みとイノベーション

• 臨床試験
• 特許情勢
• FDA承認
• イノベーション/新興技術

第9章 ケーススタディ

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 上位5つの市場リーダーの市場収益分析（%、2024年）
• 合併および買収/合弁事業（該当する場合）
• SWOT分析（市場企業5社向け）

第11章 主要企業の展望

• Intuitive Surgical Inc.
• 会社概要
• 主要経営陣
• 製品とサービス
• 財務状況（報告通り）
• 主要市場への注力と地理的プレゼンス
• 最近の動向
• Stryker Corporation
• Medtronic PLC
• Johnson &Johnson
• Siemens Healthineers AG
• Titan Medical
• Zimmer Biomet Holdings Inc
• Smith &Nephew PLC
• Asensus Surgical
• Accuray Incorporated

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に応じて変更される可能性があります。

第14章 戦略的提言

第15章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Surgical Robotics Market, By Value, In USD Million, 2018 - 2032F
• Figure 2. United States Surgical Robotics Market, By Volume, In Thousand Units, 2018 - 2032F
• Figure 3. United States Surgical Robotics Market Share, By Component, In USD Million, 2018 - 2032F
• Figure 4. United States Surgical Robotics Market Share, By Component, In Thousand Units, 2018 - 2032F
• Figure 5. United States Surgical Robotics Market Share, By Surgery Type, In USD Million, 2018 - 2032F
• Figure 6. United States Surgical Robotics Market Share, By Surgery Type, In Thousand Units, 2018 - 2032F
• Figure 7. United States Surgical Robotics Market Share, By End User, In USD Million, 2018 - 2032F
• Figure 8. United States Surgical Robotics Market Share, By End User, In Thousand Units, 2018 - 2032F
• Figure 9. United States Surgical Robotics Market Share, By Region, In USD Million, 2018 - 2032F
• Figure 10. United States Surgical Robotics Market Share, By Region, In Thousand Units, 2018 - 2032F
• Figure 11. By Component Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 12. By Surgery Type Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 13. By End User Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 14. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024

The United States surgical robotics market size was estimated at USD 6.96 billion in 2024 and is projected to reach USD 16.29 billion in 2032, growing at a CAGR of 11.21% from 2025 to 2032. Multiple factors are contributing to the growth of United States surgical robotics market such as increasing use of minimally invasive procedures, growing incidence of chronic diseases, increasing geriatric population, technological advancements, increasing penetration of surgical robotics in ambulatory surgical centres and government schemes.

Surgical robotics technology is becoming increasingly popular in the United States as it offers several advantages over traditional surgery, such as precision, reduced blood loss, and faster recovery times. The United States surgical robotics market is focussing on expanding applications in new surgical fields such as neurosurgery, SBRT (stereotactic body radiotherapy) and orthopaedics.

Growing Incidence of Chronic Diseases and Increasing Geriatric Population

The United States surgical robotics market is facing two significant trends that are expected to shape its growth in the coming years. First, there is a growing incidence of chronic diseases, which require surgical intervention. Chronic diseases such as cancer, cardiovascular disease, and neurological disorders are becoming increasingly prevalent in the United States population, leading to a higher demand for surgical procedures. Second, the geriatric population in the United States is also increasing. As people age, they are more likely to develop chronic diseases and require surgical intervention. The geriatric population is expected to nearly double by 2060, reaching 98 million, which will further increase the demand for surgical procedures.

Increasing Use of Surgical Robotics in Minimally Invasive Procedures

The use of surgical robotics in minimally invasive procedures has been steadily increasing in the United States. This method typically results in increased comfort, lower blood loss, decreased duration of hospital stays, and quicker recoveries, enabling surgeons to perform difficult-to-reach sections of the body and gauge over the obscured areas, boosting moral of the patients in United States to choose robotic surgery, which boosts the market.

Growing Emphasis on Advanced Surgical Training

The growing emphasis on advanced surgical training is driving the growth of the United States surgical robotics market by ensuring surgeons are proficient in using these sophisticated surgical robots. As more healthcare professionals receive specialized training, the adoption of robotic-assisted surgeries increases, leading to improved surgical outcomes, reduced recovery times, and higher patient satisfaction. This trend is supported by technological advancements and a rising demand for minimally invasive procedures, further propelling the market's expansion. In order to ensure that medical professionals have appropriate training and education, leading players of the market are providing novel products and technologies to various innovation and education centers. For instance, in June 2024, Stryker partnered with Atrium Health's IRCAD North America to establish a state-of-the-art surgical training center in Charlotte, North Carolina. This center will focus on advanced education in minimally invasive and image-guided surgery, utilizing Stryker's innovative medical and robotic technologies. Stryker's involvement underscores its commitment to advancing medical education and healthcare delivery. Such efforts are expected to enhance the skills of the medical professionals and increase their proficiency in handling surgical robots, thus augmenting the market's demand.

Technological advancements Driving Market Growth

The da Vinci Surgical System, developed by Intuitive Surgical, is currently the most widely used surgical robot in the United States. It has been approved by the FDA for a variety of procedures, including prostatectomies, hysterectomies, and cardiac surgeries. Connectivity and data analytics are two ways by which Intuitive Surgical is continuing to innovate in surgical robotics. Intuitive Surgical's goal is to improve the operating room experience for robotic surgeons and deliver real-time data so that doctors can learn how to perform better surgery. Other companies are also developing surgical robots with new features and capabilities. For example, Medtronic's Hugo system allows for more natural and intuitive movements, while Asensus Surgical's Senhance Surgical system offers haptic feedback to surgeons. Additionally, researchers are exploring the use of artificial intelligence and machine learning in surgical robotics. These technologies have the potential to improve surgical outcomes by providing real-time analysis and guidance to surgeons.

Increasing Penetration of Surgical Robotics in Ambulatory Surgical Centres (ACSs)

According to a survey conducted by Healthcare BlueBook and HealthSmart, ASCs reduce the cost of outpatient surgery by USD 38 billion per year since these facilities provide a lower-cost site of care than hospital outpatient departments. Every year, Medicare and its beneficiaries save more than USD 2.6 billion because they pay less for operations performed in ASCs than hospitals do for the identical procedures. When patients receive care in an ASC, their co-payments are also lower. Due to cost savings, the number of surgical procedures performed in ASCs and outpatient settings has increased rapidly, while hospital in-patient visits have decreased.

Government Schemes Accelerating Market Expansion

One of the main initiatives is the National Robotics Initiative (NRI), which was launched by the United States government in 2011 to accelerate the development and deployment of robots that can work alongside humans to enhance productivity, safety, and quality of life. The NRI includes funding opportunities for research in a variety of fields, including healthcare robotics. In addition, the National Institute of Biomedical Imaging and Bioengineering (NIBIB), which is part of the National Institutes of Health (NIH), has been funding research in surgical robotics for many years. The NIBIB has funded research on a wide range of surgical robots, including those for minimally invasive surgery, microsurgery, and robot-assisted rehabilitation. Overall, the United States government has recognized the potential of surgical robotics to improve patient outcomes and reduce healthcare costs and has been actively investing in research and development in this field.

Impact of COVID-19 on the United States Surgical Robotics Market

The COVID-19 pandemic had a significant impact on the United States surgical robotics market. While the market had been growing steadily prior to the pandemic, the pandemic led to a decrease in the number of elective surgeries and a shift in focus towards treating COVID-19 patients. But the demand for minimally invasive procedures increased due to the need for shorter hospital stays and reduced exposure to the virus. Manufacturing and trading of products and accessories were also hindered as a result of disrupted supply chains due to limited supplies and workforce.

Impact of Russia-Ukraine War on the United States Surgical Robotics Market

The war between Russia and Ukraine indirectly impacted the United States surgical robotics market through economic and political factors. For example, the conflict led to economic sanctions and trade restrictions between the United States and Russia, this could have affected the market by disrupting supply chains or increasing the cost of materials required for surgical robotics.

Key Player Landscape and Outlook

The United States Surgical Robotics Market is dominated by Intuitive Surgical with their da Vinci system being the most widely used in surgical robotics. Stryker's Mako robotic arm assisted surgery provides them a strong presence in the orthopaedic surgical robotics market. Medtronic, Zimmer Biomet, and Smith & Nephew and other players also have a significant presence in the market.

Johnson & Johnson's Ottava seeks to compete with Intuitive Surgical's da Vinci robot, implying that intense competition in the future will drive innovation for robotic surgery across a wide range of indications. CMR Surgical partnered with Johnson & Johnson's Ethicon division with the aim of increasing CMR Surgical's commercial reach in selective markets. The partnership will commence with private institutions in Italy, France, Germany, and Brazil, with CMR and Johnson & Johnson's sales teams offering bundled portfolios to surgeons.

Table of Contents

1. Research Methodology

2. Product Overview

3. Executive Summary

4. The United States Surgical Robotics Market Outlook, 2018-2032F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share & Forecast
  • 4.2.1. By Component
    • 4.2.1.1. System
    • 4.2.1.2. Accessories
    • 4.2.1.3. Services
  • 4.2.2. By Surgery Type
    • 4.2.2.1. Gynaecology
    • 4.2.2.2. Urology
    • 4.2.2.3. Neurosurgery
    • 4.2.2.4. Orthopaedic
    • 4.2.2.5. General Surgery
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Ambulatory Surgical Centres
  • 4.2.4. By Region
    • 4.2.4.1. Northeast
    • 4.2.4.2. Southwest
    • 4.2.4.3. West
    • 4.2.4.4. Southeast
    • 4.2.4.5. Midwest
  • 4.2.5. By Company Market Share (%), 2024

5. The United States Surgical Robotics Devices Market Mapping, 2024

• 5.1. By Component
• 5.2. By Surgery Type
• 5.3. By End-user
• 5.4. By Region

6. Macro Environment and Industry Structure

• 6.1. Supply Demand Analysis
• 6.2. Import Export Analysis
• 6.3. Value Chain Analysis
• 6.4. PESTEL Analysis of the Surgical Robotics Devices Market
  • 6.4.1. Political Factors
  • 6.4.2. Economic System
  • 6.4.3. Social Implications
  • 6.4.4. Technological Advancements
  • 6.4.5. Environmental Impacts
  • 6.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 6.5. Porter's Five Forces Analysis
  • 6.5.1. Supplier Power
  • 6.5.2. Buyer Power
  • 6.5.3. Substitution Threat
  • 6.5.4. Threat from New Entrant
  • 6.5.5. Competitive Rivalry

7. Market Dynamics

• 7.1. Trends and Developments
• 7.2. Growth Drivers
• 7.3. Growth Inhibitors

8. Regulatory Framework and Innovation

• 10.1 Clinical Trials
• 10.2 Patent Landscape
• 10.3 FDA Approvals
• 10.4 Innovations/Emerging Technologies

9. Case Studies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2024)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)

11. Key Players Outlook

• 11.1. Intuitive Surgical Inc.
  • 11.1.1. Company Details
  • 11.1.2. Key Management Personnel
  • 11.1.3. Products & Services
  • 11.1.4. Financials (As reported)
  • 11.1.5. Key Market Focus & Geographical Presence
  • 11.1.6. Recent Developments
• 11.2. Stryker Corporation
• 11.3. Medtronic PLC
• 11.4. Johnson & Johnson
• 11.5. Siemens Healthineers AG
• 11.6. Titan Medical
• 11.7. Zimmer Biomet Holdings Inc
• 11.8. Smith & Nephew PLC
• 11.9. Asensus Surgical
• 11.10. Accuray Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer